FilingReader Intelligence
Orchid Pharma acquires Allecra Therapeutics assets
August 5, 2025 at 04:09 PM UTC•By FilingReader AI
Orchid Pharma Limited received French court approval to acquire assets of Allecra Therapeutics SAS, effective August 1, 2025.
The acquisition follows an earlier intimation on July 30, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:ORCHPHARMA•Bombay Stock Exchange
News Alerts
Get instant email alerts when Orchid Pharma publishes news
Free account required • Unsubscribe anytime